查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1468502

中性粒細胞減少症治療市場報告（按治療方法（集落刺激因子、抗生素、抗真菌藥物、抗病毒藥物）、配銷通路（醫院藥房、零售藥房、線上藥房）和地區）2024-2032 年

Neutropenia Treatment Market Report by Treatment (Colony-Stimulating Factors, Antibiotics, Antifungals, Antivirals), Distribution channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 137 Pages | 商品交期: 2-3個工作天內

價格

2023年，全球IMARC Group中性白血球減少症治療市場規模達153億美元。雲端平台的日益普及、智慧型手機銷售的不斷上升以及廣泛的研發 (R&D) 活動是推動市場發展的一些關鍵因素。

中性粒細胞減少症是一種以幫助身體抵抗感染的白血球 (WBC) 計數異常低為特徵的疾病。它是由各種情況或疾病引起的，包括感染、化療、先天性骨髓異常、自體免疫疾病和某些藥物（藥物引起的中性粒細胞減少症）。嗜中性球是在骨髓中產生的，骨髓是較大骨骼（如椎骨、肋骨和骨盆）中的海綿組織。中性粒細胞減少症的治療包括抗生素、抗真菌和抗病毒藥物，透過消滅攻擊身體的有害真菌、酵母和細菌來幫助對抗感染。這些藥物有助於降低感染的可能性並刺激骨髓產生更多的白血球。

中性白血球減少症治療市場趨勢：

對中性粒細胞減少症和化療相關副作用的認知不斷提高是推動市場成長的關鍵因素之一。與此一致，對膠囊和片劑形式且給藥途徑方便的口服藥物的需求不斷成長，有利於市場成長。此外，主要參與者積極傳播有關中性粒細胞減少症的預防措施、早期診斷和有效治療的相關資訊和知識，這反過來又推動了市場的成長。此外，群眾對可用治療替代方案的認知不斷增強，這是另一個促進成長的因素。除此之外，製造商還專注於推出具有成本效益的中性粒細胞減少症治療藥物，這正在促進市場成長。此外，利用新型藥物傳遞方法有助於提高患者的便利性，進而提高患者的依從性，對市場成長產生正面影響。除此之外，發燒性中性粒細胞減少症藥物的增加以及促進和生產生物學名藥的新立法的實施正在為市場創造積極的前景。該市場的另一個推動力是透過線上零售入口網站（例如註冊網站）輕鬆獲得藥物，這提供了以實惠的價格訂購和購買藥物的便利性。其他因素，包括廣泛的研發（R&D）活動、創新和有效藥物的推出、癌症發病率上升、由於基礎設施改善而更容易獲得醫療保健設施、消費者支出能力不斷增強以及政府實施各種促進癌症發展的舉措公共衛生，預計將推動市場成長。

本報告回答的關鍵問題

  • 全球中性白血球減少症治療市場有多大？
  • 2024-2032年全球嗜中性白血球減少症治療市場的預期成長率為何？
  • 推動全球中性白血球減少症治療市場的關鍵因素是什麼？
  • COVID-19 對全球嗜中性白血球減少症治療市場有何影響？
  • 根據治療方法，全球中性白血球減少症治療市場的詳細情形如何？
  • 基於配銷通路的全球中性粒細胞減少症治療市場的詳細情形如何？
  • 全球中性粒細胞減少症治療市場的關鍵區域有哪些？
  • 全球中性粒細胞減少症治療市場的主要參與者/公司有哪些？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球中性白血球減少症治療市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依處理方式

  • 集落刺激因子
    • 市場走向
    • 市場預測
  • 抗生素
    • 市場走向
    • 市場預測
  • 抗黴菌藥
    • 市場走向
    • 市場預測
  • 抗病毒藥
    • 市場走向
    • 市場預測

第 7 章：市場區隔：按配銷通路

  • 醫院藥房
    • 市場走向
    • 市場預測
  • 零售藥局
    • 市場走向
    • 市場預測
  • 網路藥局
    • 市場走向
    • 市場預測

第 8 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 9 章：促進因素、限制與機會

  • 概述
  • 促進要素
  • 限制
  • 機會

第 10 章：價值鏈分析

第 11 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 12 章：價格分析

第13章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Amgen Inc.
    • BeyondSpring Inc.
    • Kyowa Hakko Kirin Co. Ltd. (Kirin Holdings Company Limited)
    • Pfizer Inc.
    • Sandoz Inc. (Novartis AG)
    • Spectrum Pharmaceuticals Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Viatris Inc.
Product Code: SR112024A6852

The global neutropenia treatment market size reached US$ 15.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 23.8 Billion by 2032, exhibiting a growth rate (CAGR) of 4.9% during 2024-2032. The increasing adoption of cloud platforms, escalating sales of smartphones and extensive research and development (R&D) activities represent some of the key factors driving the market.

Neutropenia is a disease characterized by an abnormally low count of white blood cells (WBCs) that help the body fight infections. It is caused by various situations or diseases, including infections, chemotherapy, congenital bone marrow abnormalities, autoimmune disorders, and some medications (drug-induced neutropenia). Neutrophils are made in the bone marrow, which is the spongy tissue found in larger bones, such as the vertebrae, ribs, and pelvis. Neutropenia treatment includes antibiotics, antifungals, and antiviral medications that help fight against infection by destroying harmful fungi, yeast, and bacteria that attack the body. These medications assist in reducing the likelihood of infections and stimulate the bone marrow to produce more white blood cells.

Neutropenia Treatment Market Trends:

The rising awareness of neutropenia and chemotherapy-related side effects is one of the key factors driving the market growth. In line with this, the increasing demand for oral drugs that are available in capsule and tablet form and consist of convenient routes of administration is favoring the market growth. Moreover, key players are actively engaged in disseminating relevant information and knowledge regarding preventive measures, early diagnosis, and effective treatment of neutropenia, which, in turn, is propelling the market growth. Furthermore, the increasing awareness among the masses regarding the available treatment alternatives is acting as another growth-inducing factor. In addition to this, manufacturers are focusing on the introduction of cost-effective medicines for neutropenia treatment, which is facilitating the market growth. Additionally, the utilization of novel drug delivery methods that helps in improving patient convenience, which leads to improved patient adherence, is positively influencing the market growth. Besides this, the increase in febrile neutropenia medications and the implementation of new legislation to promote and manufacture biosimilars are creating a positive outlook for the market. The market is also driven by the easy availability of medications through online retail portals, such as registered websites, which provides convenience of ordering and procurement of medications at affordable price-points. Other factors, including extensive research and development (R&D) activities, the introduction of innovative and effective drugs, rising incidences of cancer, easy access to healthcare facilities owing to improved infrastructure, increasing expenditure capacities of consumers and the implementation of various government initiatives for promoting public health, are anticipated to drive the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global neutropenia treatment market, along with forecasts at the global, regional, and country level from 2024-2032. Our report has categorized the market based on treatment and distribution channel.

Treatment Insights:

Colony-Stimulating Factors

Antibiotics

Antifungals

Antivirals

The report has provided a detailed breakup and analysis of the neutropenia treatment market based on the treatment. This includes colony-stimulating factors, antibiotics, antifungals and antivirals. According to the report, colony-stimulating factors represented the largest segment.

Distribution channel Insights:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

The report has provided a detailed breakup and analysis of the neutropenia treatment market based on the distribution channel. This includes hospital, retail, and online pharmacies. According to the report, hospital pharmacies represented the largest segment.

Regional Insights:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for neutropenia treatment. Some of the factors driving the North America neutropenia treatment market included increasing demand for internet-enabled services by enterprises, extensive research and development (R&D) activities, and various technological advancements.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global neutropenia treatment market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Amgen Inc., BeyondSpring Inc., Kyowa Hakko Kirin Co. Ltd. (Kirin Holdings Company Limited), Pfizer Inc., Sandoz Inc. (Novartis AG), Spectrum Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., Viatris Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

  • 1. How big is the global neutropenia treatment market?
  • 2. What is the expected growth rate of the global neutropenia treatment market during 2024-2032?
  • 3. What are the key factors driving the global neutropenia treatment market?
  • 4. What has been the impact of COVID-19 on the global neutropenia treatment market?
  • 5. What is the breakup of the global neutropenia treatment market based on the treatment?
  • 6. What is the breakup of the global neutropenia treatment market based on the distribution channel?
  • 7. What are the key regions in the global neutropenia treatment market?
  • 8. Who are the key players/companies in the global neutropenia treatment market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Neutropenia Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Treatment

  • 6.1 Colony-Stimulating Factors
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Antibiotics
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Antifungals
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Antivirals
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Distribution Channel

  • 7.1 Hospital Pharmacies
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Retail Pharmacies
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Online Pharmacies
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 Drivers, Restraints, and Opportunities

  • 9.1 Overview
  • 9.2 Drivers
  • 9.3 Restraints
  • 9.4 Opportunities

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Amgen Inc.
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 BeyondSpring Inc.
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
    • 13.3.3 Kyowa Hakko Kirin Co. Ltd. (Kirin Holdings Company Limited)
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Pfizer Inc.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 Sandoz Inc. (Novartis AG)
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 SWOT Analysis
    • 13.3.6 Spectrum Pharmaceuticals Inc.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
      • 13.3.6.4 SWOT Analysis
    • 13.3.7 Teva Pharmaceutical Industries Ltd.
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Viatris Inc.
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Neutropenia Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Neutropenia Treatment Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Neutropenia Treatment Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Neutropenia Treatment Market: Breakup by Treatment (in %), 2023
  • Figure 5: Global: Neutropenia Treatment Market: Breakup by Distribution Channel (in %), 2023
  • Figure 6: Global: Neutropenia Treatment Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Neutropenia Treatment (Colony-Stimulating Factors) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 8: Global: Neutropenia Treatment (Colony-Stimulating Factors) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 9: Global: Neutropenia Treatment (Antibiotics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Neutropenia Treatment (Antibiotics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Neutropenia Treatment (Antifungals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Neutropenia Treatment (Antifungals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Neutropenia Treatment (Antivirals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Neutropenia Treatment (Antivirals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Neutropenia Treatment (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Neutropenia Treatment (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Neutropenia Treatment (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Neutropenia Treatment (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Neutropenia Treatment (Online Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Neutropenia Treatment (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: North America: Neutropenia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: North America: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: United States: Neutropenia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: United States: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Canada: Neutropenia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Canada: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Asia-Pacific: Neutropenia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Asia-Pacific: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: China: Neutropenia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: China: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Japan: Neutropenia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Japan: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: India: Neutropenia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: India: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: South Korea: Neutropenia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: South Korea: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Australia: Neutropenia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Australia: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Indonesia: Neutropenia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Indonesia: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Others: Neutropenia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Others: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Europe: Neutropenia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Europe: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Germany: Neutropenia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Germany: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: France: Neutropenia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: France: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: United Kingdom: Neutropenia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: United Kingdom: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Italy: Neutropenia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Italy: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Spain: Neutropenia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Spain: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Russia: Neutropenia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Russia: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Others: Neutropenia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Others: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Latin America: Neutropenia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Latin America: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Brazil: Neutropenia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Brazil: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Mexico: Neutropenia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Mexico: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Others: Neutropenia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Others: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Middle East and Africa: Neutropenia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Middle East and Africa: Neutropenia Treatment Market: Breakup by Country (in %), 2023
  • Figure 69: Middle East and Africa: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Global: Neutropenia Treatment Industry: Drivers, Restraints, and Opportunities
  • Figure 71: Global: Neutropenia Treatment Industry: Value Chain Analysis
  • Figure 72: Global: Neutropenia Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Neutropenia Treatment Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: Neutropenia Treatment Market Forecast: Breakup by Treatment (in Million US$), 2024-2032
  • Table 3: Global: Neutropenia Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 4: Global: Neutropenia Treatment Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 5: Global: Neutropenia Treatment Market: Competitive Structure
  • Table 6: Global: Neutropenia Treatment Market: Key Players